2022
Country immunization policies for refugees across 20 low-middle income and 20 high-income countries
Elharake JA, Omer SB, Schwartz JL. Country immunization policies for refugees across 20 low-middle income and 20 high-income countries. Vaccine 2022, 40: 6017-6022. PMID: 36123257, DOI: 10.1016/j.vaccine.2022.09.032.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19Developed CountriesDeveloping CountriesHumansImmunizationImmunization ProgramsPandemicsPolicyRefugeesVaccine-Preventable DiseasesConceptsVaccine-preventable diseasesHigh-income countriesImmunization policyNational routine immunization programRoutine immunization programLow immunization coverageMiddle-income countriesImmunization programsImmunization coverageHealth conditionsCOVID-19 pandemicDiseaseLMICsRefugee populationsLower middle incomeHigher numberImmunization
2021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 398: 2186-2192. PMID: 34793741, PMCID: PMC8592561, DOI: 10.1016/s0140-6736(21)02507-1.Peer-Reviewed Original ResearchMeSH KeywordsBehavior TherapyCommunicationCOVID-19COVID-19 VaccinesHumansImmunization ProgramsPoliticsSARS-CoV-2United StatesVaccination RefusalConceptsCOVID-19 vaccineSARS-CoV-2 infectionCOVID-19 vaccination campaignCOVID-19 vaccine acceptanceCOVID-19 vaccine programPfizer-BioNTech vaccineEmergency use authorisationVaccine programVaccine acceptanceVaccination campaignVaccine refusalCommunity transmissionUS FoodDrug AdministrationInadequate uptakeVaccineBehavioral intervention strategiesBest interventionLancet CommissionLow uptakeIntervention strategiesCOVID-19Evidence-based educationFull approvalUS residents
2020
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Affairs 2020, 40: 42-52. PMID: 33211536, PMCID: PMC7931245, DOI: 10.1377/hlthaff.2020.02054.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineVaccine efficacyCoronavirus disease 2019 (COVID-19) vaccinesSignificant vaccine hesitancyClinical outcomesClinical trialsVaccination programVaccine hesitancyEpidemic severityVaccineAuthorized vaccinesHealth officialsCumulative infectionsEfficacyVaccine productionDistribution programSeverityOutcomesUrgent needHospitalizationVaccinationInfectionTrialsGlobal efforts
2016
When Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination
Schwartz JL, Mahmoud A. When Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination. Health Affairs 2016, 35: 208-211. PMID: 26858371, DOI: 10.1377/hlthaff.2015.1438.Peer-Reviewed Original Research
2011
Ethics of vaccination programs
Schwartz JL, Caplan AL. Ethics of vaccination programs. Current Opinion In Virology 2011, 1: 263-267. PMID: 22440783, DOI: 10.1016/j.coviro.2011.05.009.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsHumansImmunization ProgramsInfluenza VaccinesInfluenza, HumanVaccinationViral VaccinesVirus DiseasesConceptsEthical challengesEthical issuesRisk controversiesEthicsFundamental principlesVaccination programUnique issuesHealth of individualsInfluenza vaccination campaignGlobal vaccination programsChildhood vaccinesIssuesVaccination activitiesVaccination campaignGlobal eradicationEventual designPublic healthControversyScientistsOngoing evaluationNationsPrinciplesRecent developmentsCommunityHealth